Association between depression and metabolic dysfunction-associated fatty liver disease/significant fibrosis-Reference-Cited by-同舟云学术

Association between depression and metabolic dysfunction-associated fatty liver disease/significant fibrosis

Published:2023-05 Issue: Volume:329 Page:184-191
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Kim Donghee,Dennis Brittany B.,Cholankeril George,Ahmed Aijaz

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference42 articles.

1. Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study;Abeysekera;Lancet Gastroenterol. Hepatol.,2020

2. Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis;Balakrishnan;Clin. Gastroenterol. Hepatol.,2021

3. NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk;Ballestri;Adv. Ther.,2017

4. Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis;Bhanji;Hepatology,2017

5. Depression as a risk factor of organic diseases: an international integrative review;Bica;J. Nurs. Scholarsh.,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the possible therapeutic mechanism of Danzhixiaoyao pills in depression and MAFLD based on "Homotherapy for heteropathy": A network pharmacology and molecular docking;Heliyon;2024-08

2. Persons with metabolic dysfunction‐associated steatotic liver disease are at increased risk of severe depression;Liver International;2024-07

3. Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity;Acta Diabetologica;2024-04-29

4. The prevalence and predictors of metabolic dysfunction‐associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults;Journal of Pediatric Gastroenterology and Nutrition;2024-04-16

5. MAFLD as part of systemic metabolic dysregulation;Hepatology International;2024-04-09